Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions-Reference-Cited by-同舟云学术

Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions

Published:2024-02 Issue:2 Volume:80 Page:335-351
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ratziu Vlad^ORCID,Hompesch Marcus^ORCID,Petitjean Mathieu,Serdjebi Cindy^ORCID,Iyer Janani S.,Parwani Anil V.,Tai Dean,Bugianesi Elisabetta^ORCID,Cusi Kenneth,Friedman Scott L.^ORCID,Lawitz Eric^ORCID,Romero-Gómez Manuel^ORCID,Schuppan Detlef^ORCID,Loomba Rohit,Paradis Valérie,Behling Cynthia,Sanyal Arun J.

Publisher

Elsevier BV

Subject

Hepatology

Reference124 articles.

1. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort;Harrison;J Hepatol,2021

2. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons;Le;J Hepatol,2023

3. Burden of non-alcoholic fatty liver disease in asia, the Middle East and North africa: data from global burden of disease 2009-2019;Golabi;J Hepatol,2021

4. Noncirrhotic nonalcoholic steatohepatitis with liver fibrosis: developing drugs for treatment guidance for industry;Usa Food and Drug Administration,2018

5. Reflection paper on regulatory requirements for the development of medicinal products for chronic non 6 infectious liver diseases,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannose Supplementation Curbs Liver Steatosis and Fibrosis in Murine MASH by Inhibiting Fructose Metabolism;2024-01-17

2. Preliminary Fatty Liver Disease Grading Using General-Purpose Online Large Language Models: ChatGPT-4 or Bard?;Journal of Hepatology;2023-11